Cambridge-based Healthera’s £2m boost to transform digital pharmacy service in North America

Healthera has secured £2million in strategic investment to accelerate its mission to transform digital pharmacy services – and the new finance boosts its current Series A round to £5.6m.

The company – which already provides technology for 1,700 UK pharmacies and more than a million patients – is now poised for significant expansion across the UK and North America and into new revenue verticals, including private medicine prescribing and the end-to-end management of clinical services.

Healthera’s healthcare marketplace reinvents the pharmacy operating model, enabling patients to access faster medicine delivery and personalised medical care local to them.

Healthera, which is based at St John’s Innovation Centre, was founded in Cambridge in 2015 by Cambridge University graduates. The initial app reminded people when to take their medicines. It was developed by three engineering students – Quintus Liu, Martin Hao, and Jin Dai – and was quickly taken up by local pharmacies and their patients.

Today, Healthera provides patients with medicines, healthcare services and products through the largest digital platform of pharmacies and GPs in the UK, including national chains and independent providers.

In 2024, Healthera processed over 5 million digital prescriptions, with partners outperforming the market by 10 per cent.

Navid Ghasemi, owner of Newport Pharmacy, a Healthera partner, praised the platform’s impact: “Healthera has significantly increased our prescription volume and helped us reach new patients. Their technology and personalised service are exceptional.”

The new funding round was completed by private investors through the network of Committed Capital, who led the investment.

Else Thomson, investment director at Committed Capital, said: “We are proud to lead this latest investment round in Healthera.

“Healthera has consistently demonstrated strong vision and execution in redefining digital pharmacy services, and we believe the company are uniquely positioned to lead the sector’s evolution both in the UK and internationally.

“We’re excited to back Quintus and the team as they continue to expand throughout the UK and support pharmacies and customers with their market leading technology.”

Previous investors in Healthera include Cambridge Enterprise, Accelerated Digital Ventures (Legal and General), NHS England and Innovate UK.

“This investment is a catalyst for Healthera’s next phase of growth,” said Quintus Liu, CEO and co-founder of Healthera.

“We’re excited to build on our UK success, deepen our technological offerings and bring our innovative solutions to the Canadian market.”